APA

Brassat U., Balabanov S., Bali D., Dierlamm J., Braig M., Hartmann U., Sirma H., Günes C., Wege H., Fehse B., Gontarewicz A., Dikomey E., Borgmann K. & Brümmendorf T. H. (20110121). Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells. : Experimental hematology.

Chicago

Brassat Ute, Balabanov Stefan, Bali Daniel, Dierlamm Judith, Braig Melanie, Hartmann Ulrike, Sirma Hüseyin, Günes Cagatay, Wege Henning, Fehse Boris, Gontarewicz Artur, Dikomey Ekkehard, Borgmann Kerstin and Brümmendorf Tim H. 20110121. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells. : Experimental hematology.

Harvard

Brassat U., Balabanov S., Bali D., Dierlamm J., Braig M., Hartmann U., Sirma H., Günes C., Wege H., Fehse B., Gontarewicz A., Dikomey E., Borgmann K. and Brümmendorf T. H. (20110121). Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells. : Experimental hematology.

MLA

Brassat Ute, Balabanov Stefan, Bali Daniel, Dierlamm Judith, Braig Melanie, Hartmann Ulrike, Sirma Hüseyin, Günes Cagatay, Wege Henning, Fehse Boris, Gontarewicz Artur, Dikomey Ekkehard, Borgmann Kerstin and Brümmendorf Tim H. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells. : Experimental hematology. 20110121.